Question 1

What are the potential benefits of using Magtrace® compared to the standard method?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II clinical trial (NCT07552597). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my participation affect my treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II clinical trial (NCT07552597). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the risks or side effects associated with the new tracer?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II clinical trial (NCT07552597). Contact the study team or your healthcare provider for specific answers.

Question 4

How will the study procedures be conducted, and what will I need to do?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II clinical trial (NCT07552597). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I am not eligible for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II clinical trial (NCT07552597). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II clinical trial (NCT07552597). Contact the study team or your healthcare provider for specific answers.

What this study is about